Inactive Instrument

Highlights MDxHealth SA Euronext Bruxelles

Equities

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering	Mar. 12	CI
MDxHealth SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 06	CI
Earnings Flash (MDXH) MDXHEALTH Posts Q4 Revenue $19.4M	Mar. 06	MT
MDxHealth SA Maintains Earnings Guidance for the Year 2024	Mar. 06	CI
MDxHealth Preliminary Q4 Revenue Tops Consensus; 2024 Outlook Exceeds Estimates; Shares Jump After Hours	Jan. 08	MT
MDxHealth SA Provides Earnings Guidance for the Fourth Quarter and Full Year 2023 and Year 2024	Jan. 08	CI

No results for this search